How AI can advance research and treatment of CNS disorders

More News! 14 Nov 2022

Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease

Empyrean Neuroscience launches with $22M to target CNS disorders

Research identifies new treatment target for CNS injury and neurological disease


Gate Neurosciences emerges from stealth to tackle CNS diseases

EditForce and Mitsubishi Tanabi Pharma to work on gene therapy for CNS

Startup Scout 13 Oct 2017

This French Biotech is Taking On CNS Diseases of the Young and the Elderly